Compass Therapeutics
CMPX
CMPX
34 hedge funds and large institutions have $85.4M invested in Compass Therapeutics in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
58% less capital invested
Capital invested by funds: $202M → $85.4M (-$116M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
34
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.33M | |
| 2 | +$1.2M | |
| 3 | +$411K | |
| 4 |
Millennium Management
New York
|
+$37.7K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$34K |
Top Sellers
| 1 | -$2.22M | |
| 2 | -$1.8M | |
| 3 | -$1,000K | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$793K |
| 5 |
OCA
Octagon Capital Advisors
New York
|
-$761K |